The MarketWatch News Department was not involved in the creation of this content. BillionToOne Expands Its Leadership in Hemolytic Disease of the Fetus and Newborn (HDFN) and Extends Fetal Antigen ...
BillionToOne Expands Its Leadership in Hemolytic Disease of the Fetus and Newborn (HDFN) and Extends Fetal Antigen Testing to Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT) MENLO PARK, Calif., ...
Forward-looking statements in this press release include, but are not limited to, statements regarding the clinical performance of UNITY Fetal Antigen NIPT. These statements are based on management's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results